aux injections intramusculaires dans la syphilis. Ann Mal Vener 1925; 20: 321–39. 4 Browne BA, Holder EP, Rupnick L. Nonsteroidal anti-inflammatory drugs and necrotizing fasciitis. Am J Health Syst Pharm 1996; 53: 265–9. 5 Pillans PI, O’Connor N. Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann Pharmacother 1995; 29: 264–6. 6 Stricker BH, van Kasteren BJ. Diclofenac-induced isolated myonecrosis and the Nicolau syndrome. Ann Intern Med 1992; 117: 1058. 7 Faucher L, Marcou D. What syndrome is this? Nicolau’s syndrome. Pediatr Dermatol 1995; 12: 187–90. 8 Nagore E, Torrelo A, Gonzales-Mediero I, Zambrano A. Livedoid skin necrosis (Nicolau’s syndrome) due to triple vaccine (DTP) injection. Br J Dermatol 1997; 137: 1011–31. 9 Menasse R, Hedwall PR, Kraetz J et al. Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol Suppl 1978; 22: 5–16.
[1]
Aj Smith,et al.
Topical tacrolimus in the management of peristomal pyoderma gangrenosum
,
2001,
The Journal of dermatological treatment.
[2]
C. Griffiths,et al.
Parastomal pyoderma gangrenosum: clinical features and management.
,
2000,
Journal of the American Academy of Dermatology.
[3]
Jolles,et al.
Combination oral and topical tacrolimus in therapy‐resistant pyoderma gangrenosum
,
1999,
The British journal of dermatology.
[4]
Vente,et al.
Topical tacrolimus for pyoderma gangrenosum
,
1998,
The British journal of dermatology.
[5]
H. Schuppe,et al.
Topical tacrolimus for pyoderma gangrenosum
,
1998,
The Lancet.